We are live on ! Find out more
PNT

POINT Biopharma Global Inc. Common Stock
PNT

Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings

18 hedge funds and large institutions have $186M invested in POINT Biopharma Global Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+18
Holders Change %
–
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$20.5M
2
BC
Boxer Capital
California
+$20.5M
3
PA
Perceptive Advisors
New York
+$20.5M
4
ACA
Avoro Capital Advisors
New York
+$13.6M
5
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$13.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$21.6M +$20.5M +1,500,000 New
BC
2
Boxer Capital
California
$21.6M +$20.5M +1,500,000 New
PA
3
Perceptive Advisors
New York
$21.6M +$20.5M +1,500,000 New
ACA
4
Avoro Capital Advisors
New York
$14.4M +$13.6M +1,000,000 New
BCLSI
5
Bain Capital Life Sciences Investors
Massachusetts
$14.4M +$13.6M +1,000,000 New
BI
6
BVF Inc
California
$14.4M +$13.6M +1,000,000 New
Franklin Resources
7
Franklin Resources
California
$14.4M +$13.6M +1,000,000 New
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$13.3M +$12.6M +921,822 New
Wellington Management Group
9
Wellington Management Group
Massachusetts
$13.1M +$12.4M +908,671 New
Citadel Advisors
10
Citadel Advisors
Florida
$7.2M +$6.83M +500,814 New
CAM
11
Cormorant Asset Management
Massachusetts
$7.19M +$6.82M +500,000 New
LGM
12
Logos Global Management
California
$7.19M +$6.82M +500,000 New
RI
13
RTW Investments
New York
$7.05M +$6.68M +490,000 New
FCMI
14
Foresite Capital Management IV
California
$5.03M +$4.77M +350,000 New
Janus Henderson Group
15
Janus Henderson Group
United Kingdom
$1.79M +$1.7M +124,666 New
TD Asset Management
16
TD Asset Management
Ontario, Canada
$708K +$672K +49,262 New
MIM
17
Monashee Investment Management
Massachusetts
$680K +$645K +47,271 New
SFM
18
Sphera Funds Management
Israel
$288K +$273K +20,000 New

PNT Hedge Fund Activity: Q3 2020 in Review

18 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in POINT Biopharma Global Inc. Common Stock (PNT) for Q3 2020, worth a combined $186M.

Buyers outnumbered sellers: 18 funds opened new PNT positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $20.5M.

  • 18 institutional investors held POINT Biopharma Global Inc. Common Stock (PNT) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $186M of POINT Biopharma Global Inc. Common Stock stock for Q3 2020.
  • 18 funds opened new POINT Biopharma Global Inc. Common Stock positions in Q3 2020 and 0 closed out, a net change of +18 holders.
  • The largest POINT Biopharma Global Inc. Common Stock buyer in Q3 2020 was BlackRock, an estimated $20.5M added.

Based on aggregated 13F filings for Q3 2020.